Calendar Aprea Therapeutics, Inc.

Equities

APRE

US03836J2015

Delayed Nasdaq 03:09:29 2024-04-26 pm EDT 5-day change 1st Jan Change
5.2 USD -2.80% Intraday chart for Aprea Therapeutics, Inc. -2.99% +10.43%

Chart calendar Aprea Therapeutics, Inc.

58cc26b9ef20d58715912f0.NjkKKhcSVP_nJwiwixRbffKjEGqxoNQsXu0pLB-et_4.eUNpeFR_PayyaHiEyEQ0J4fUJBjf0qNbLIN2TivL-tMPTGRiREAxi7htYw~e96d389631967bd66af20d62575bab3c

Upcoming events on Aprea Therapeutics, Inc.

2024-05-12 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-26 Q4 2024 Earnings Release (Projected)

Past events on Aprea Therapeutics, Inc.

2024-04-10 12:00 pm American Association for Cancer Research Meeting - Abstract Number:7121
2024-04-10 12:00 pm American Association for Cancer Research Meeting - Abstract Number: 7117
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Abstract Number: CT196
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Abstract Number: CT195
2024-03-26 07:45 am Q4 2023 Earnings Release
2024-02-01 09:00 am DDR Inhibitors Summit
2023-11-09 04:05 pm Q3 2023 Earnings Release
2023-10-31 11:00 am Investor Meeting - Key Opinion Leader
2023-10-14 12:30 pm AACR-NCI-EORTC International Conference - Abstract No:C034
2023-10-14 12:30 pm AACR-NCI-EORTC International Conference - Abstract No:C147
2023-09-11 04:30 pm H.C. Wainwright Global Investment Conference
2023-08-23 09:00 am Annual General Meeting
2023-08-10 07:30 am Q2 2023 Earnings Release
2023-06-21 01:00 pm Maxim Group Virtual Healthcare Conference
2023-06-05 02:15 pm BIO International Convention
2023-05-15 04:05 pm Q1 2023 Earnings Release
2023-04-19 09:00 am American Association for Cancer Research Meeting - Poster No - ATRN-119/ATRN-W1051
2023-03-30 12:05 pm Q4 2022 Earnings Release
2023-03-14 10:00 am Oppenheimer Healthcare Conference
2023-01-26 01:30 pm DDR Inhibitors Summit

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,58
0,68
-14.15%

0,20

EBITDA
Million USD
Released
Forecast
Spread
0,00


-113
-119
4.39%
-15,5
-15,6
0.87%

-20,5

EBIT
Million USD
Released
Forecast
Spread
0,00


-113
-118
3.51%
-15,5
-16,0
3.14%

-19,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-113
-116
3.24%
-14,3
-14,9
4.29%

-18,9

Net income
Million USD
Released
Forecast
Spread
-37,1


-113
-116
3.13%
-14,3
-14,9
4.43%

-18,9

EPS
USD
Released
Forecast
Spread
-34,8


-68,0
-87,3
22.08%
-3,95
-3,46
-14.27%

-2,60

Announcement Date15/03/2230/03/2326/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,25
0,00
-
0,32
0,08
283.38%

0,10


0,00


0,00


0,00


0,20


0,00

EBITDA
Million USD
Released
Forecast
Spread






-2,65
-7,80
65.97%
-4,62
-3,20
-44.44%
-3,65
-4,10
10.94%
-3,52
-4,10
14.11%
-3,67
-3,80
3.42%

-4,60


-4,80


-5,50


-5,70




EBIT
Million USD
Released
Forecast
Spread
-22,4
-7,88
-184.8%
-4,20
-8,81
52.34%
-2,65
-6,24
57.52%
-4,62
-4,50
-2.72%
-3,65
-5,09
28.19%
-3,52
-4,62
23.76%
-3,67
-4,36
15.78%

-4,35


-4,54


-4,92


-5,11


-5,49

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-98,3
-7,70
-1175.59%
-4,02
-8,62
53.32%
-2,44
-6,22
60.72%
-4,38
-3,10
-41.29%
-3,26
-5,07
35.76%
-3,20
-4,35
26.39%
-3,44
-4,07
15.35%

-4,30


-4,60


-5,20


-5,30


-5,56

Net income
Million USD
Released
Forecast
Spread
-98,3
-7,64
-1186.61%
-4,02
-8,46
52.45%
-2,44
-6,20
60.63%
-4,38
-3,10
-41.29%
-3,26
-5,14
36.53%
-3,20
-4,35
26.39%
-3,44
-4,07
15.36%

-4,30


-4,60


-5,20


-5,30


-5,56

EPS
USD
Released
Forecast
Spread
-86,8
-7,00
-1140%
-2,40
-1,80
-33.33%
-0,92
-3,22
71.43%
-1,34
-1,51
10.96%
-0,87
-1,38
36.96%
-0,86
-1,16
26.07%
-0,92
-0,77
-18.97%

-0,78


-0,81


-0,83


-0,54


-1,00

Announcement Date11/08/2209/11/2230/03/2315/05/2310/08/2309/11/2326/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. APRE Stock
  4. Calendar Aprea Therapeutics, Inc.